[HTML][HTML] Role of lipocalin 2 in stroke
RY Zhao, PJ Wei, X Sun, DH Zhang, QY He, J Liu… - Neurobiology of …, 2023 - Elsevier
Stroke is the second leading cause of death worldwide; however, the treatment choices
available to neurologists are limited in clinical practice. Lipocalin 2 (LCN2) is a secreted …
available to neurologists are limited in clinical practice. Lipocalin 2 (LCN2) is a secreted …
Vasopressin and copeptin release during sepsis and septic shock
DA Gomes, RL de Almeida Beltrão… - Peptides, 2021 - Elsevier
Sepsis is defined as a potentially fatal organ dysfunction caused by a dysregulated host
response to infection. Despite tremendous progress in the medical sciences, sepsis remains …
response to infection. Despite tremendous progress in the medical sciences, sepsis remains …
[HTML][HTML] Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2 …
J Liu, SY Pang, SY Zhou, QY He, RY Zhao, Y Qu… - Redox Biology, 2024 - Elsevier
Background Disruption of the blood-brain barrier (BBB) is a major contributor to hemorrhagic
transformation (HT) in patients with acute ischemic stroke (AIS) following intravenous …
transformation (HT) in patients with acute ischemic stroke (AIS) following intravenous …
Thrombomodulin Serum Levels—A Predictable Biomarker for the Acute Onset of Ischemic Stroke
AL Zaharia, D Tutunaru, VD Oprea, CE Tănase… - Current Issues in …, 2024 - mdpi.com
The early diagnosis of acute ischemic stroke (AIS) can be challenging in cases presenting
with a scarcity of clinical signs, normal cerebral imaging in early stages and a lack of specific …
with a scarcity of clinical signs, normal cerebral imaging in early stages and a lack of specific …
Copeptin as biomarker for acute ischemic stroke prognosis and revascularization treatment efficacy
AI Vasile, C Tiu, C Badiu - Frontiers in Neurology, 2024 - frontiersin.org
Introduction Pro-arginine vasopressin consists of three peptides: arginine-vasopressin,
neurophysin II, and copeptin. AVP is released by the neurohypophysis in response to …
neurophysin II, and copeptin. AVP is released by the neurohypophysis in response to …
Elevated Serum HMGB1 Levels and Their Association with Recurrence of Acute Ischaemic Stroke
L Shen, J Yang, Z Zhu, W Li, J Cui… - Journal of Inflammation …, 2024 - Taylor & Francis
Purpose The study aimed to investigate the correlation between baseline serum levels of
high mobility group box 1 (HMGB1) and the recurrence of acute ischemic stroke (AIS) …
high mobility group box 1 (HMGB1) and the recurrence of acute ischemic stroke (AIS) …
Identification of Hub Genes and Pathways of Middle Cerebral Artery Occlusion in Aged Rats Using the Gene Expression Omnibus Database
J Guo, YZ Yan, J Chen, Y Duan… - Critical Reviews™ in …, 2024 - dl.begellhouse.com
Stroke remained the leading cause of disability in the world, and the most important non-
modifiable risk factor was age. The treatment of stroke for elder patients faced multiple …
modifiable risk factor was age. The treatment of stroke for elder patients faced multiple …
急性脑梗死超早期血浆TM, TAFI, IL-6, TNF-α 水平与梗死体积的关系及诊断价值.
吴彬， 范秀博， 董贞， 王举波… - Progress in Modern …, 2024 - search.ebscohost.com
摘要目的: 探讨急性脑梗死超早期血浆血栓调节蛋白(TM), 凝血酶激活纤溶抑制物(TAFI),
白细胞介素-6 (IL-6) 及肿瘤坏死因子-琢(TNF-琢) 水平与患者梗死体积的关系及对梗死体积的 …
白细胞介素-6 (IL-6) 及肿瘤坏死因子-琢(TNF-琢) 水平与患者梗死体积的关系及对梗死体积的 …
[PDF][PDF] 短暂性脑缺血发作患者血管内皮功能与脑梗死发生风险的相关性
刘晓娟， 程宏 - 医学临床研究 - journal07.magtech.org.cn
[目的] 探讨短暂性脑缺血发作(TIA) 患者血管内皮功能与脑梗死发生风险的相关性.[方法]
选择2019 年3 月至2022 年3 月西安工会医院收治的89 例TIA 患者, 根据患者TIA 后7d …
选择2019 年3 月至2022 年3 月西安工会医院收治的89 例TIA 患者, 根据患者TIA 后7d …